(VIANEWS) - BlackRock New York Municipal Income Trust (BNY), Grifols, S.A. (GRFS), Simulations Plus (SLP) are the highest payout ratio stocks on this list.
We have collected information concerning stocks with the highest payout ratio at the moment. The payout ratio in itself isn't a promise of good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. BlackRock New York Municipal Income Trust (BNY)
65.43% Payout Ratio
BlackRock New York Municipal Income Trust is a closed ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC.
Volume
Today's last reported volume for BlackRock New York Municipal Income Trust is 46755, 15.97% below its average volume of 55646.
As stated by Morningstar, Inc., the next dividend payment is on Feb 13, 2022, the estimated forward annual dividend rate is 0.68 and the estimated forward annual dividend yield is 5.19%.
Year-on-year quarterly revenue growth grew by 46.1%, now sitting on 15.16M for the twelve trailing months.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.07%.
Volatility
BlackRock New York Municipal Income Trust's last day, week, and month's current intraday variation average was 0.31%, 0.42%, and 0.45%, respectively.
BlackRock New York Municipal Income Trust's highest amplitude of average volatility was 0.54% (day), 0.82% (last week), and 1.12% (last month), respectively.
BlackRock New York Municipal Income Trust's Stock Yearly Top and Bottom Value
BlackRock New York Municipal Income Trust's stock is valued at $13.07 at 01:23 EST, way below its 52-week high of $16.44 and above its 52-week low of $12.86.
BlackRock New York Municipal Income Trust's Moving Average
BlackRock New York Municipal Income Trust's worth is under its 50-day moving average of $14.11 and way below its 200-day moving average of $14.85.2. Grifols, S.A. (GRFS)
56.4% Payout Ratio
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products primarily hemoderivatives.
Volume
Today's last reported volume for Grifols, S.A. is 566573, 33.22% below its average volume of 848543.
As claimed by Morningstar, Inc., the next dividend payment is on Jun 2, 2021, the estimated forward annual dividend rate is 0.91 and the estimated forward annual dividend yield is 8.39%.
Grifols, S.A.'s sales growth this year is expected to be negative 6.4% and 7.9% for next year.
Year-on-year quarterly revenue growth declined by 2.3%, now sitting on 5.2B for the twelve trailing months.
Grifols, S.A.'s sales growth is negative 3.6% for the current quarter and negative 0.2% for the next. The company's growth estimates for the ongoing quarter and the next is negative 21.6% and negative -30.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.73%.
Volatility
Grifols, S.A.'s last day, week, and month's current intraday variation average was 2.83%, 1.95%, and 1.54%, respectively.
Grifols, S.A.'s highest amplitude of average volatility was 2.87% (day), 2.91% (last week), and 2.98% (last month), respectively.
Grifols, S.A.'s Stock Yearly Top and Bottom Value
Grifols, S.A.'s stock is valued at $12.48 at 01:23 EST, way under its 52-week high of $19.07 and way above its 52-week low of $10.10.
Grifols, S.A.'s Moving Average
Grifols, S.A.'s worth is higher than its 50-day moving average of $11.52 and way under its 200-day moving average of $14.04.3. Simulations Plus (SLP)
48% Payout Ratio
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide.
Volume
Today's last reported volume for Simulations Plus is 82879, 35.07% below its average volume of 127659.
As claimed by Morningstar, Inc., the next dividend payment is on Jan 27, 2022, the estimated forward annual dividend rate is 0.24 and the estimated forward annual dividend yield is 0.6%.
Simulations Plus's sales growth this year is expected to be 13.8% and 18% for next year.
Year-on-year quarterly revenue growth grew by 16%, now sitting on 48.18M for the twelve trailing months.
The company's growth estimates for the current quarter and the next is negative 6.7% and negative -16.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.33%.
Volatility
Simulations Plus's last day, week, and month's current intraday variation average was 0.23%, 1.86%, and 1.91%, respectively.
Simulations Plus's highest amplitude of average volatility was 3.46% (day), 5.17% (last week), and 4.22% (last month), respectively.
Simulations Plus's Stock Yearly Top and Bottom Value
Simulations Plus's stock is valued at $39.87 at 01:23 EST, way under its 52-week high of $73.67 and way above its 52-week low of $35.18.
Simulations Plus's Moving Average
Simulations Plus's worth is under its 50-day moving average of $43.76 and way below its 200-day moving average of $46.75.4. Western Asset Global Highome Fund (EHI)
47.86% Payout Ratio
Western Asset Global High Income Fund Inc is a closed ended fixed income mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC.
Volume
Today's last reported volume for Western Asset Global Highome Fund is 43824, 15.54% below its average volume of 51893.
As maintained by Morningstar, Inc., the next dividend payment is on Jan 20, 2022, the estimated forward annual dividend rate is 0.8 and the estimated forward annual dividend yield is 8.19%.
Year-on-year quarterly revenue growth declined by 49.5%, now sitting on 29.27M for the twelve trailing months.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.82%.
Volatility
Western Asset Global Highome Fund's last day, week, and month's current intraday variation average was 0.23%, 1.00%, and 1.00%, respectively.
Western Asset Global Highome Fund's highest amplitude of average volatility was 0.80% (day), 1.29% (last week), and 1.52% (last month), respectively.
Western Asset Global Highome Fund's Stock Yearly Top and Bottom Value
Western Asset Global Highome Fund's stock is valued at $8.79 at 01:23 EST, way below its 52-week high of $10.77 and above its 52-week low of $8.77.
Western Asset Global Highome Fund's Moving Average
Western Asset Global Highome Fund's worth is below its 50-day moving average of $9.53 and way below its 200-day moving average of $10.11.5. CONMED Corporation (CNMD)
39.6% Payout Ratio
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide.
Volume
Today's last reported volume for CONMED Corporation is 287736, 14.42% above its average volume of 251464.
As maintained by Morningstar, Inc., the next dividend payment is on Dec 13, 2021, the estimated forward annual dividend rate is 0.8 and the estimated forward annual dividend yield is 0.55%.
CONMED Corporation's sales growth this year is expected to be 17.7% and 8.9% for next year.
Year-on-year quarterly revenue growth grew by 4.6%, now sitting on 989.49M for the twelve trailing months.
CONMED Corporation's sales growth is 10.3% for the ongoing quarter and 18.4% for the next. The company's growth estimates for the ongoing quarter and the next is 26.2% and 15.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.65%.
Volatility
CONMED Corporation's last day, week, and month's current intraday variation average was 0.05%, 1.27%, and 1.77%, respectively.
CONMED Corporation's highest amplitude of average volatility was 3.48% (day), 3.35% (last week), and 3.48% (last month), respectively.
CONMED Corporation's Stock Yearly Top and Bottom Value
CONMED Corporation's stock is valued at $148.30 at 01:23 EST, below its 52-week high of $159.11 and way higher than its 52-week low of $115.00.
CONMED Corporation's Moving Average
CONMED Corporation's value is higher than its 50-day moving average of $138.06 and higher than its 200-day moving average of $136.79.6. Dolby Laboratories (DLB)
37.3% Payout Ratio
Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices.
Volume
Today's last reported volume for Dolby Laboratories is 656339, 22.2% above its average volume of 537070.
According to Morningstar, Inc., the next dividend payment is on Feb 14, 2022, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1.33%.
Dolby Laboratories's sales growth this year is anticipated to be 7% and 8.2% for next year.
Year-on-year quarterly revenue growth declined by 9.8%, now sitting on 1.24B for the twelve trailing months.
The company's growth estimates for the present quarter and the next is negative 12.1% and 43.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.79%.
Volatility
Dolby Laboratories's last day, week, and month's current intraday variation average was 0.21%, 1.00%, and 1.84%, respectively.
Dolby Laboratories's highest amplitude of average volatility was 2.10% (day), 1.65% (last week), and 2.91% (last month), respectively.
Dolby Laboratories's Stock Yearly Top and Bottom Value
Dolby Laboratories's stock is valued at $75.30 at 01:23 EST, way under its 52-week high of $104.74 and higher than its 52-week low of $74.82.